Cosmetic cross-reference

Titanium Dioxide

CAS 13463-67-7

Titanium Dioxide (CAS 13463-67-7) is a pharmaceutical compound with 0 bioactivity targets and 46 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE DrugCentral 055904D152D6

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Titanium Dioxide

CAS Number

13463-67-7

UNII

15FIX9V2JP

InChIKey

GWEVSGVZZGPLCZ-UHFFFAOYSA-N

ChEMBL ID

CHEMBL1201136

DrugCentral Struct ID

4237

Source Match

DrugCentral (CAS), FDA GSRS (UNII)

Synonyms and normalized names

CI 77891

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE NLM DailyMed 1 label row

Drug Label Active Ingredients

Active ingredient and active moiety rows from source drug product labels.

Product	Ingredient	Active Moiety	Effective
Neutrogena MINERAL UV TINT FACE MEDIUM DEEP SPF 30	TITANIUM DIOXIDE 15FIX9V2JP	TITANIUM DIOXIDE	20260505

SOURCE DrugCentral 43 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PT	Drug AE	LLR	MedDRA
Macular degeneration	263	1034.96	10025409
Chronic sinusitis	93	321.653	10009137
Paraesthesia oral	92	281.63	10057372
Procedural pain	92	272.67	10064882
Vaginal flatulence	39	160.284	10064227
Therapeutic product effect incomplete	109	141.202	10082200
Dyspepsia	98	141.187	10013946
Female genital tract fistula	41	138.879	10061149
Drug ineffective	303	126.751	10013709
Vaginal discharge	39	122.886	10046901
Proctitis	38	122.1	10036774
Radiculopathy	39	114.367	10037779
Pyrexia	182	93.665	10037660
Anal inflammation	21	88.976	10050247
SARS-CoV-2 test negative	18	75.236	10084273
Frequent bowel movements	40	74.022	10017367
Oral candidiasis	39	73.15	10030963
Colitis ulcerative	42	72.757	10009900
Infusion related reaction	97	67.723	10051792
Weight decreased	113	64.373	10047895
Malaise	124	55.076	10025482
Rectal haemorrhage	45	51.988	10038063
Proctalgia	22	51.192	10036772
Constipation	89	50.58	10010774
Accident	21	49.4	10000369
Haematochezia	46	48.839	10018836
Colitis	43	48.719	10009887
Appendicolith	18	44.338	10074458
Nausea	174	41.051	10028813
Pain	141	33.837	10033371
Haemorrhoids	23	29.987	10019022
Appendicitis	18	27.257	10003011
Ventricular fibrillation	20	25.176	10047290
Abdominal pain	76	23.329	10000081
Ascites	29	22.351	10003445
Body temperature increased	23	22.225	10005911
Language disorder	9	21.752	10074869
Febrile neutropenia	52	21.4	10016288
Cardiogenic shock	20	20.935	10007625
Sepsis	59	20.865	10040047
Off label use	147	20.621	10053762
Transferrin saturation abnormal	4	19.711	10079855
Pneumonia aspiration	25	19.586	10035669

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 6 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
CI 77891	38323	SU	MTHSPL
TITANIUM DIOXIDE	38323	SU	MTHSPL
Titanium Dioxide	38323	SU	MTHSPL
Titanium dioxide	38323	SU	MTHSPL
titanium dioxide	38323	SU	MTHSPL
titanium dioxide	38323	IN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Titanium Dioxide used for in pharmaceutical contexts?

Titanium Dioxide (CAS 13463-67-7) appears in DailyMed active-ingredient label rows, including Neutrogena MINERAL UV TINT FACE MEDIUM DEEP SPF 30.

What are the known adverse events for Titanium Dioxide?

Titanium Dioxide has 46 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Macular degeneration, Chronic sinusitis, Paraesthesia oral, Procedural pain, Vaginal flatulence. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Titanium Dioxide also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Titanium Dioxide with EU status "restricted".

What clinical phase is Titanium Dioxide in?

No phase 1-4 clinical development badge is rendered for Titanium Dioxide because the matched compound identifier rows do not contain a max-phase value.